Case 1-2009: A 57-year-old man with progressive cognitive decline

New England Journal of Medicine

Volumn 360, Issue 2, 2009, Pages 171-181

  Costello, Daniel J ^a,b   Eichler, Florian S ^a,b   Grant, P Ellen ^a,b   Auluck, Pavan K ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CEFTRIAXONE; DOCUSATE SODIUM; ETIRACETAM; GADOLINIUM; HALOPERIDOL; LORAZEPAM; LORENZO OIL; METOPROLOL; ORGANIC SOLVENT; PHENYTOIN; THIAMINE; FATTY ACID;

ADRENOLEUKODYSTROPHY; ADULT; ARTICLE; BRAIN ATROPHY; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONFUSION; CONJUNCTIVA TUMOR; DEMENTIA; DIET THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISORIENTATION; EEG ABNORMALITY; EMERGENCY HEALTH SERVICE; EVISCERATION; EYELID TUMOR; HEPATITIS C; HORMONE SUBSTITUTION; HUMAN; LEUKOENCEPHALOPATHY; MALE; MELANOMA; MENTAL HEALTH; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SUBSTANCE ABUSE; THETA RHYTHM; VERBAL COMMUNICATION; X CHROMOSOME LINKED DISORDER; BIOPSY; BLOOD; BRAIN; CHEMISTRY; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; FATALITY; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY; STEREOTACTIC PROCEDURE; TOXICITY AND INTOXICATION;

ADRENOLEUKODYSTROPHY; BIOPSY; BRAIN; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FATAL OUTCOME; FATTY ACIDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MELANOMA; MIDDLE AGED; NEUROTOXICITY SYNDROMES; STEREOTAXIC TECHNIQUES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 58149400363     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0807820     Document Type: Article

References (23)

1. Filley CM, Kleinschmidt-DeMasters BK. Toxic leukoecephalopathy. N Engl J Med 2001;345:425-32.
2. Schenker S, Bay MK. Medical problems associated with alcoholism. Adv Intern Med 1998;43:27-78.
3. Ryan A, Molloy FM, Farrell MA, Hutchinson M. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J Neurol Neurosurg Psychiatry 2005;76:1014-6.
4. Kriegstein AR, Shungu DC, Millar WS, et al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation ("chasing the dragon"). Neurology 1999;53:1765-73.
5. Wolters EC, van Wijngaarden GK, Stam FC, et al. Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet 1982;2:1233-7.
6. Barnett MH, Miller LA, Reddel SW, Davies L. Reversible delayed leukoencephalopathy following intravenous heroin overdose. J Clin Neurosci 2001;8:165-7.
7. Visser I, Lavini C, Booij J, et al. Cerebral impairment in chronic solvent-induced encephalopathy. Ann Neurol 2008;63:572-80.
8. Prockop L. Neurotoxic volatile substances. Neurology 1979;29:862-5.
9. Coker SB. The diagnosis of childhood neurodegenerative disorders presenting as dementia in adults. Neurology 1991;41:794-8.
10. Kornfeld M, Moser AB, Moser HW, Kleinschmidt-DeMasters B, Nolte K, Phelps A. Solvent vapor abuse leukoencephalopathy: comparison to adrenoleukodystrophy. J Neuropathol Exp Neurol 1994;53:389-98.
11. Schlote W, Molzer B, Peiffer J, et al. Adrenoleukodystrophy in an adult female: a clinical, morphological, and neurochemical study. J Neurol 1987;235:1-9.
12. Takeda S, Ohama E, Ikuta F. Adrenoleukodystrophy - early ultrastructural changes in the brain. Acta Neuropathol 1989;78:124-30.
13. Szpak GM, Lewandowska E, Schmidt-Sidor B, et al. Adult schizophrenic-like variant of adrenoleukodystrophy. Folia Neuropathol 1996;34:184-92.
14. Simon DK, Rodriguez ML, Frosch MP, Quackenbush EJ, Feske SK, Natowicz MR. A unique familial leukodystrophy with adult onset dementia and abnormal glycolipid storage: a new lysosomal disease? J Neurol Neurosurg Psychiatry 1998;65:251-4.
15. Kemp S, Wanders RJ. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment. Mol Genet Metab 2007;90:268-76.
16. Mosser J, Lutz Y, Stoeckel ME, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet 1994;3:265-71.
17. Liu LX, Janvier K, Berteaux-Lecellier V, Cartier N, Benarous R, Aubourg P. Homo-and heterodimerization of peroxisomal ATP-binding cassette half-transporters. J Biol Chem 1999;274:32738-43.
18. Moser H, Smith K, Watkins P, et al. X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill, 2001:3257-301.
19. van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 2001;49:186-94.
20. Eichler F, Mahmood A, Loes D, et al. Magnetic resonance imaging detection of lesion progression in adult patients with X-linked adrenoleukodystrophy. Arch Neurol 2007;64:659-64.
21. Bezman L, Moser AB, Raymond GV, et al. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001;49:512-7.
22. Moser HW. Therapy of X-linked adrenoleukodystrophy. NeuroRx 2006;3:246-53.
23. Peters C, Charnas LR, Tan Y, et al. Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881-8.